Hematological parameters in atrial fibrillation: A literature review
- PMID: 40741025
- PMCID: PMC12304830
- DOI: 10.4330/wjc.v17.i7.108363
Hematological parameters in atrial fibrillation: A literature review
Abstract
Atrial fibrillation (AF) is a frequent cardiac arrhythmia in the general population, which is associated with an increased risk of several health issues. It has been demonstrated that hematological variables predict the occurrence and recurrence of AF. This review article specifically only focuses on haemoglobin, hematocrit, platelet count, white blood cells (WBCs), lymphocytes, neutrophils, monocytes, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR) and red blood cells in the pathophysiology of AF. It emphasizes that there is a higher risk of new-onset AF linked with both low and high haemoglobin levels. A quantitative investigation showed that hematocrit is not linked to the development of AF. The predictive significance of platelet count was reported in nonvalvular AF patients. WBCs are consistent inflammatory markers that are associated with postoperative new-onset AF. Inflammation and in particular, leukocyte activation predisposes to AF. Enhanced migratory activity in circulating and local monocytes may play a pivotal role in the pathogenesis of progression in atrial remodeling in AF patients. In particular, the peripheral eosinophil and left atrial diameter may be important in mediating inflammation and atrial remodeling in AF. In nonvalvular AF patients, PLR may be an independent risk factor for left atrial appendage thrombogenic milieu. NLR and MLR changes are associated with early recurrence of AF, and NLR change is related to late recurrence of AF after pulmonary vein isolation. Red blood cell distribution width and left atrial dimension were the only independent risk factors associated with AF.
Keywords: Atrial fibrillation; Blood cells; Hematological parameters; Platelets; Red blood cells; White blood cells.
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Figures
References
-
- Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16:217–221. - PubMed
-
- Weymann A, Ali-Hasan-Al-Saegh S, Sabashnikov A, Popov AF, Mirhosseini SJ, Liu T, Lotfaliani M, Sá MPBO, Baker WLL, Yavuz S, Zeriouh M, Jang JS, Dehghan H, Meng L, Testa L, D'Ascenzo F, Benedetto U, Tse G, Nombela-Franco L, Dohmen PM, Deshmukh AJ, Linde C, Biondi-Zoccai G, Stone GW, Calkins H Surgery And Cardiology-Group Imcsc-Group IMOC. Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis. Med Sci Monit Basic Res. 2017;23:179–222. - PMC - PubMed
-
- Rafaqat S, Sharif S, Naz S, Majeed M, Saqib M, Farzana Rashid, Ali Q. The Role of Hematological Parameters in Atrial Fibrillation Risk Assessment. Proc Pak Acad Sci B. 2023;60:635–641.
Publication types
LinkOut - more resources
Full Text Sources
